BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 20724929)

  • 1. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.
    Katsiki N; Hatzitolios AI
    Curr Opin Obstet Gynecol; 2010 Dec; 22(6):466-76. PubMed ID: 20724929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.
    Goldenberg N; Glueck C
    Minerva Ginecol; 2008 Feb; 60(1):63-75. PubMed ID: 18277353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE
    Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis.
    Li XJ; Yu YX; Liu CQ; Zhang W; Zhang HJ; Yan B; Wang LY; Yang SY; Zhang SH
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):332-9. PubMed ID: 21050251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
    Palomba S; Falbo A; Russo T; Orio F; Tollino A; Zullo F
    Minerva Ginecol; 2008 Feb; 60(1):77-82. PubMed ID: 18277354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinediones for treatment of polycystic ovary syndrome.
    Stout DL; Fugate SE
    Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients.
    Palomba S; Falbo A; Orio F; Zullo F
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):364-73. PubMed ID: 18660688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
    Kuscu NK; Koyuncu FM
    Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study.
    Naka KK; Kalantaridou SN; Kravariti M; Bechlioulis A; Kazakos N; Calis KA; Makrigiannakis A; Katsouras CS; Chrousos GP; Tsatsoulis A; Michalis LK
    Fertil Steril; 2011 Jan; 95(1):203-9. PubMed ID: 20684955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolinedione treatment in PCOS--an update.
    Glintborg D; Andersen M
    Gynecol Endocrinol; 2010 Nov; 26(11):791-803. PubMed ID: 20528570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-sensitizing agents in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
    Franks S
    Clin Endocrinol (Oxf); 2011 Feb; 74(2):148-51. PubMed ID: 21121941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S221-3. PubMed ID: 17055827
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M; Pehlivanov B; Terzieva D
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):93-8. PubMed ID: 16360262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA; Hernández Marín I; Ayala AR
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of metformin in polycystic ovary syndrome.
    Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R
    Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries. Do insulin-sensitizing drugs increase ovulation rates for women with PCOS?
    Andy C; Flake D; French L
    J Fam Pract; 2005 Feb; 54(2):156, 159-60. PubMed ID: 15689292
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.